Raymond James & Associates Avanos Medical, Inc. Transaction History

Raymond James & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$31.89 - $47.34 $221,699 - $329,107	-6,952 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$32.06 - $44.0 $26,577 - $36,476	829 Added 13.54%	6,952 $260,000
Q2 2019 Aug 06, 2019	BUY	$37.68 - $46.52 $21,213 - $26,190	563 Added 10.13%	6,123 $267,000
Q1 2019 May 06, 2019	SELL	$39.84 - $51.04 $37,688 - $48,283	-946 Reduced 14.54%	5,560 $237,000
Q4 2018 Feb 11, 2019	SELL	$41.16 - $66.67 $11,812 - $19,134	-287 Reduced 4.22%	6,506 $291,000
Q3 2018 Nov 14, 2018	BUY	$55.13 - $72.65 $374,498 - $493,511	6,793 New	6,793 $465,000

274

42.2M

5.4K

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $751M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.